Biometric Characteristics of the Eye With Microcornea/Microphthalmia and Congenital Cataract Before And After Cataract Extraction
Launched by ALEXANDRIA UNIVERSITY · Feb 17, 2021
Trial Information
Current as of June 25, 2025
Unknown status
Keywords
ClinConnect Summary
Eyes with congenital cataract have usually small cornea due to developmental delay of the globe. Recognition of microcornea/microphthalmia may be important as a potential contributor to the development of aphakic glaucoma after cataract surgery. Biometrics characteristics of eyes with m/m before and after removal of the cataractous lens can justify the occurrence of postoperative complications, including glaucoma.
Aim of the study: to report on the changes in the anterior segment biometric characteristics after cataract extraction in eyes with microcornea/microphthalmia with congenital cat...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Children presenting with congenital cataract in one or both eyes and with a horizontal corneal diameter less than 11 mm and/or an axial length less than 2 standard deviations for age of the child, less than 18mm in children under one year and less than 20mm in those less than 1year (cases).
- • 2. Children presenting with congenital cataract in one or both eyes with otherwise normal ocular biometric characteristics (controls).
- Exclusion Criteria:
- • 1.Children presenting with congenital cataract associated with other ocular anomalies other than microcornea/microphthalmia
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, Alexandria/ Egypt, Egypt
Patients applied
Trial Officials
Gloria Nshokano Simba, MBBch
Principal Investigator
Alexandria University
Nader L Bayoumi, Professor
Study Director
Alexandria University
Nihal Mohamed Elshakankiri, Professor
Study Chair
Alexandria University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials